...
机译:一种安全和有效的抗CD19汽车T细胞疗法
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Univ Southern Calif Keck Sch Med Dept Mol Microbiol &
Immunol Norris Comprehens Canc Ctr Los;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Univ Southern Calif Keck Sch Med Dept Mol Microbiol &
Immunol Norris Comprehens Canc Ctr Los;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Marino Biotechnol Corp Beijing Peoples R China;
Univ Southern Calif Keck Sch Med Dept Mol Microbiol &
Immunol Norris Comprehens Canc Ctr Los;
Univ Southern Calif Keck Sch Med Dept Mol Microbiol &
Immunol Norris Comprehens Canc Ctr Los;
Peking Univ Canc Hosp &
Inst Key Lab Carcinogenesis &
Translat Res Dept Lymphoma Beijing;
Univ Southern Calif Keck Sch Med Dept Mol Microbiol &
Immunol Norris Comprehens Canc Ctr Los;
机译:一种安全和有效的抗CD19汽车T细胞疗法
机译:抗CD19 / CD20嵌合抗原受体T细胞免疫疗法在复发或难治性B细胞恶性肿瘤中的疗效和安全性:META分析
机译:关于UCART19的安全性,细胞动力学和抗白血病活性的初步数据,同种异体抗CD19汽车T细胞产物,在成人和儿科患者中,高风险的CD19 +复发/难治性B细胞急性淋巴细胞白血病
机译:草药性强抗氧化剂对耐药性卵巢腺癌细胞株的影响
机译:靶向碳水化合物的卟啉靶向光动力疗法(PDT)。通过坏死和凋亡均能有效诱导癌细胞死亡的解决方案:全细胞选择方法的溶液相组合文库。
机译:抗CD19 CAR T细胞疗法对110例高危B细胞急性淋巴细胞白血病的疗效和安全性
机译:抗CD19汽车T细胞疗法在110例B细胞急性淋巴细胞白血病具有高风险特征的疗效和安全性